Milestone Pharmaceuticals Inc. Common Shares
MIST •
Buy Open
Signal type
Buy
Status
Open
Open Price
$1.80
Stop Loss
$1.51
Performance
12.78%
Days Open
7
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 8, 2026
Open Price $1.80
Stop Loss $1.51
Timespan Day
Company Profile
Name Milestone Pharmaceuticals Inc. Common Shares
Ticker MIST
Market Cap $103.72M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $2.03
List Date May 9, 2019
Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Website Open Company Website